AMWLHealthcare · Health Information ServicesThe 7 Wall Street analysts covering American Well Corp. hold a median 12-month price target of $12 — -3.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 89 of 100 as at 4 Nov 2026 — inside the top quartile. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores American Well Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (91): Analysts have, on balance, been raising their forecasts.
Volatility (23): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on AMWL, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −3.5% from it.
Of the 20 most recent actions, 7 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 4 Nov 2026 | Stifel | Maintains | Hold | $11 → $12 |
| 4 Nov 2026 | TD Cowen | Maintains | Hold | $12 → $13 |
| 4 Nov 2026 | Wells Fargo | Maintains | Overweight | $16 → $18 |
| 13 Aug 2026 | Truist Securities | Maintains | Hold | $7.50 → $12 |
| 5 Aug 2026 | Needham | Reiterates | Hold | — |
| 5 Aug 2026 | Needham | Reiterates | Hold | — |
| 17 July 2026 | Wells Fargo | Maintains | Overweight | $9.00 → $16 |
| 17 July 2026 | Wells Fargo | Maintains | Overweight | — |
| 6 May 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 6 May 2026 | Morgan Stanley | Maintains | Equal-Weight | $6.00 → $6.50 |
| 6 May 2026 | TD Cowen | Maintains | Hold | — |
| 6 May 2026 | TD Cowen | Maintains | Hold | $5.00 → $8.00 |
| 13 Feb 2026 | Stifel | Maintains | Hold | — |
| 18 Dec 2025 | Morgan Stanley | Maintains | Equal-Weight | — |
| 5 Nov 2025 | Stifel | Maintains | Hold | — |
| 5 Nov 2025 | Wells Fargo | Maintains | Overweight | — |
| 7 Aug 2025 | Wells Fargo | Maintains | Overweight | — |
| 23 May 2025 | Piper Sandler | Reiterates | Neutral | — |
| 8 May 2025 | UBS | Maintains | Neutral | — |
| 2 May 2025 | Needham | Reiterates | Hold | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AMWL appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, American Well Corp. returned +146.3% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 86% of US stocks
Cheaper than 69% of US stocks
Cheaper than 71% of US stocks
Cheaper than 68% of US stocks
Higher than 10% of US stocks
Higher than 18% of US stocks
Higher than 65% of US stocks
Higher than 21% of US stocks
Higher than 12% of US stocks
Higher than 27% of US stocks
Higher than 25% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
American Well Corp. has a market value of $210.1M and an enterprise value of $30.5M.
Revenue in the twelve months to 30 June 2026: $218.5M. The latest quarter shrank 13.0% year on year.
Net income over the same four quarters: −$77.0M, a −35.2% net margin.
Diluted earnings per share, trailing twelve months: $−4.77.
Free cash flow in the twelve months to 30 June 2026: −$32.0M, after $5.6M of capital spending.
American Well Corp. spent $2K on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: −2.1×; forward P/E: −11.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
American Well Corp. employs 562 people — $389K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own American Well Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Amwell said it is seeing a fundamental evolution in how corporate buyers and consumers navigate digital medicine. The headline reports that one-third of adults are now using AI health tools.
Why it matters — The comments describe changing consumer and corporate-buyer behavior in digital medicine, which may be relevant to AMWL watchers tracking the company’s market context.
Amwell reported third-quarter 2026 revenue above its guidance range and a narrower adjusted EBITDA loss, citing stronger visit volumes and cost controls. The company reiterated its target of positive adjusted EBITDA and operating cash flow in the fourth quarter.
Why it matters — AMWL watchers may note the results and the company’s stated fourth-quarter profitability and cash-flow target.
Seeking Alpha published the transcript of American Well Corporation’s Q3 2026 earnings call.
Why it matters — The transcript provides AMWL watchers with the company’s remarks during its Q3 2026 earnings call.
American Well reported a third-quarter loss of $0.67 per share, slightly wider than the Zacks Consensus Estimate of a $0.66 loss. The loss narrowed from $1.74 per share a year earlier; the headline also says the company topped revenue estimates.
Why it matters — AMWL watchers may note the year-over-year reduction in per-share loss alongside the miss against the consensus loss estimate.
Amwell announced its financial results for the third quarter ended September 30, 2026. CEO Dr. Ido Schoenberg said the company’s single platform is designed to meet health plans’ and employers’ needs for engagement, outcomes, and proof.
Why it matters — The announcement reports a quarterly company update and highlights Amwell’s stated platform focus, topics relevant to AMWL watchers.
The 7 Wall Street analysts covering American Well Corp. have a median 12-month price target of $12, with estimates ranging from $11 to $18. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 7 analysts covering American Well Corp., 1 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks American Well Corp. 89 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, American Well Corp. ranks 89 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (91 of 100).
No one can know that. What the data says: the median 12-month target from 7 analysts implies -3.5% from the last close, and Ticker Nerd's factor model ranks American Well Corp. 89 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering American Well Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMWL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $11 to $18 over the next 12 months.
American Well Corp. returned +146.3% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
American Well Corporation Class A Common Stock represents ownership in American Well Corporation, a digital healthcare company focused on telehealth and hybrid care delivery. American Well provides a software platform that supports virtual medical services for health systems, health plans, employers, and government clients.
The most recent item we track (PYMNTS, 4 Nov 2026): "Amwell Says One-Third of Adults Now Using AI Health Tools". Amwell said it is seeing a fundamental evolution in how corporate buyers and consumers navigate digital medicine. The headline reports that one-third of adults are now using AI health tools.
American Well Corporation Class A Common Stock represents ownership in American Well Corporation, a digital healthcare company focused on telehealth and hybrid care delivery. American Well provides a software platform that supports virtual medical services for health systems, health plans, employers, and government clients. Its offerings include on-demand and scheduled consultations, virtual primary care, behavioral health, chronic care management, specialty care, and other remote care programs. The company’s platform is designed to help providers and payers coordinate care across urgent, acute, post-acute, and ongoing health needs. American Well Corporation is headquartered in Boston, Massachusetts, and operates in the healthcare technology and software market, where its services connect patients and clinicians through digital tools that support more flexible care delivery.
CEO Dr. Ido Schoenberg M.D. · 562 employees · United States · https://business.amwell.com
